Advertisement

Irish Journal of Medical Science (1971 -)

, Volume 187, Issue 4, pp 1133–1137 | Cite as

Festschrift for Ronan O’Connell: pouchitis, ulcerative colitis and the microbiome

  • Aonghus Lavelle
Review Article

Abstract

The hypothesis of altered bacterial communities contributing to the development of pouchitis began a scientific quest to link host mucosal factors, microbial metabolism and spatial structure of the colonic microbiome in ulcerative colitis, reaching its apotheosis with the integration of advanced spatial sampling with laser capture microdissection, mucin array profiling, molecular microbiology and next-generation sequencing technologies. This article, part of a festschrift, summarises the contributions of the O’Connell lab to the field of host-microbial interactions in inflammatory bowel disease.

Keywords

Inflammatory bowel disease Microbiome Pouchitis 

Notes

Compliance with ethical standards

Conflict of interest

The author declares no conflict of interest.

Ethical approval

This article does not contain any studies with human participants or animals performed by the author.

References

  1. 1.
    Parks AG, Nicholls RJ (1978) Proctocolectomy without ileostomy for ulcerative colitis. Br Med J 2(6130):85–88CrossRefGoogle Scholar
  2. 2.
    O'Connell PR, Pemberton JH, Kelly KA (1987) Motor function of the ileal J pouch and its relation to clinical outcome after ileal pouch-anal anastomosis. World J Surg 11(6):735–741.  https://doi.org/10.1007/bf01656596 CrossRefPubMedGoogle Scholar
  3. 3.
    McGuire B, Brannigan A, O’Connell P (2007) Ileal pouch-anal anastomosis. Br J Surg 94(7):812–823CrossRefGoogle Scholar
  4. 4.
    Mimura T, Rizzello F, Helwig U, Poggioli G, Schreiber S, Talbot IC, Nicholls RJ, Gionchetti P, Campieri M, Kamm MA (2004) Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis. Gut 53(1):108–114.  https://doi.org/10.1136/gut.53.1.108 CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Ståhlberg D, Gullberg K, Liljeqvist L, Hellers G, Löfberg R (1996) Pouchitis following pelvic pouch operation for ulcerative colitis. Dis Colon Rectum 39(9):1012–1018CrossRefGoogle Scholar
  6. 6.
    Van Assche G, Dignass A, Bokemeyer B et al (2013) Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 3: special situations. J Crohns Colitis 7(1):1–33.  https://doi.org/10.1016/j.crohns.2012.09.005 CrossRefPubMedGoogle Scholar
  7. 7.
    O'Connell P, Rankin D, Weiland L et al (1986) Enteric bacteriology, absorption, morphology and emptying after ileal pouch-anal anastomosis. Br J Surg 73(11):909–914CrossRefGoogle Scholar
  8. 8.
    den Besten G, van Eunen K, Groen AK, Venema K, Reijngoud DJ, Bakker BM (2013) The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. J Lipid Res 54(9):2325–2340.  https://doi.org/10.1194/jlr.R036012 CrossRefGoogle Scholar
  9. 9.
    Roediger W (1980) The colonic epithelium in ulcerative colitis: an energy-deficiency disease? Lancet 316(8197):712–715CrossRefGoogle Scholar
  10. 10.
    Duffy MM, Regan MC, Ravichandran P, OʼKeane C, Harrington MG, Fitzpatrick JM, O’Connell PR (1998) Mucosal metabolism in ulcerative colitis and Crohn’s disease. Dis Colon Rectum 41(11):1399–1405.  https://doi.org/10.1007/bf02237056 CrossRefGoogle Scholar
  11. 11.
    Sokol H, Seksik P, Furet J et al (2009) Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflamm Bowel Dis 15(8):1183–1189CrossRefGoogle Scholar
  12. 12.
    Duffy M, O'Mahony L, Coffey JC et al (2002) Sulfate-reducing bacteria colonize pouches formed for ulcerative colitis but not for familial adenomatous polyposis. Dis Colon Rectum 45(3):384–388CrossRefGoogle Scholar
  13. 13.
    Gibson GR, Cummings JH, Macfarlane GT (1991) Growth and activities of sulphate-reducing bacteria in gut contents of healthy subjects and patients with ulcerative colitis. FEMS Microbiol Lett (2):103–111CrossRefGoogle Scholar
  14. 14.
    Levine J, Ellis CJ, Furne JK, Springfield J, Levitt MD (1998) Fecal hydrogen sulfide production in ulcerative colitis. Am J Gastroenterol 93(1):83–87CrossRefGoogle Scholar
  15. 15.
    Coffey JC, Rowan F, Burke J, Dochery N, Kirwan WO, O’Connell PR (2009) Pathogenesis of and unifying hypothesis for idiopathic pouchitis. Am J Gastroenterol 104:1013–1023.  https://doi.org/10.1038/ajg.2008.127 CrossRefPubMedGoogle Scholar
  16. 16.
    Rowan F, Docherty NG, Murphy M, Murphy B, Coffey JC, O’Connell PR (2010) Desulfovibrio bacterial species are increased in ulcerative colitis. Dis Colon Rectum 53(11):1530–1536CrossRefGoogle Scholar
  17. 17.
    Rowan F, Docherty NG, Murphy M, Murphy TB, Coffey JC, OʼConnell PR (2010) Bacterial colonization of colonic crypt mucous gel and disease activity in ulcerative colitis. Ann Surg 252(5):869–875CrossRefGoogle Scholar
  18. 18.
    Vandeputte D, Kathagen G, D'Hoe K et al (2017) Quantitative microbiome profiling links gut community variation to microbial load. Nature 7681:507–511.  https://doi.org/10.1038/nature24460 CrossRefGoogle Scholar
  19. 19.
    Lavelle A, Lennon G, Docherty N, Balfe A, Mulcahy HE, Doherty G, O’Donoghue D, Hyland JM, Shanahan F, Sheahan K, Coffey JC, Winter DC, O’Connell PR (2013) Depth-dependent differences in community structure of the human colonic microbiota in health. PLoS One 8(11):e78835.  https://doi.org/10.1371/journal.pone.0078835 CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Png CW, Linden SK, Gilshenan KS et al (2010) Mucolytic bacteria with increased prevalence in IBD mucosa augment in vitro utilization of mucin by other bacteria. Am J Gastroenterol 105(11):2420–2428.  https://doi.org/10.1038/ajg.2010.281 CrossRefPubMedGoogle Scholar
  21. 21.
    Hall AB, Yassour M, Sauk J, Garner A, Jiang X, Arthur T, Lagoudas GK, Vatanen T, Fornelos N, Wilson R, Bertha M, Cohen M, Garber J, Khalili H, Gevers D, Ananthakrishnan AN, Kugathasan S, Lander ES, Blainey P, Vlamakis H, Xavier RJ, Huttenhower C (2017) A novel Ruminococcus gnavus clade enriched in inflammatory bowel disease patients. Genom Med 9(1):103.  https://doi.org/10.1186/s13073-017-0490-5 CrossRefGoogle Scholar
  22. 22.
    Morgan XC, Tickle TL, Sokol H, Gevers D, Devaney KL, Ward DV, Reyes JA, Shah SA, LeLeiko N, Snapper SB, Bousvaros A, Korzenik J, Sands BE, Xavier RJ, Huttenhower C (2012) Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol 13(9):R79.  https://doi.org/10.1186/gb-2012-13-9-r79 CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Lavelle A, Lennon G, O’Sullivan O, Docherty N, Balfe A, Maguire A, Mulcahy HE, Doherty G, O’Donoghue D, Hyland J, Ross RP, Coffey JC, Sheahan K, Cotter PD, Shanahan F, Winter DC, O’Connell PR (2015) Spatial variation of the colonic microbiota in patients with ulcerative colitis and control volunteers. Gut 64(10):1553–1561.  https://doi.org/10.1136/gutjnl-2014-307873 CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Earley H, Lennon G, Balfe A, Kilcoyne M, Clyne M, Joshi L, Carrington S, Martin ST, Coffey JC, Winter DC, O’Connell PR (2015) A preliminary study examining the binding capacity of Akkermansia muciniphila and Desulfovibrio spp., to colonic mucin in health and ulcerative colitis. PLoS One 10:e0135280.  https://doi.org/10.1371/journal.pone.0135280 CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Whipps J, Lewis K, Cooke R (1988) Mycoparasitism and plant disease control in fungi in biological control systems. Manchester University PressGoogle Scholar

Copyright information

© Royal Academy of Medicine in Ireland 2018

Authors and Affiliations

  1. 1.Department of Medicine, APC Microbiome IrelandUniversity College CorkCorkIreland

Personalised recommendations